Publications & Posters
Scholary publications
Cardiometabolic Disease
SRK-439
February 2024
Keystone Symposia: Obesity Causes and Consequences Conference
SRK-439, a Selective Anti-Pro and Latent Myostatin Antibody, Maintains Lean Mass and Enhances Fat Mass Loss in Models of Pharmacologically Induced Weight Loss
Immuno-Oncology
SRK-181
November 2023
Society for Immunotherapy of Cancer 2023
Safety, Efficacy, and Biomarker Results of SRK-181, a Latent TGFβ1 Inhibitor, in Anti‑PD-1 Resistant Metastatic ccRCC Patients
Immuno-Oncology
SRK-181
November 2023
Society for Immunotherapy of Cancer 2023
Establishing Proof of Mechanism in Patients: Preliminary Biomarker Data of SRK-181 (a latent Tβ1 inhibitor) from DRAGON Study
Spinal Muscular Atrophy
Apitegromab
October 2023
World Muscle Society 2023 Meeting
Effect of apitegromab on PEDI-CAT and PROMIS Fatigue questionnaire at 36 months in patients with spinal muscular atrophy
Spinal Muscular Atrophy
Apitegromab
October 2023
World Muscle Society 2023 Meeting
Effect of apitegromab on motor function at 36 months in patients with nonambulatory spinal muscular atrophy aged 2-12 years old
Fibrosis
SRK-373
September 2023
Discovery on Target 2023
